1488PVemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial. (23rd October 2018) - Mazières, J; Montané, L; Barlesi, F; Quantin, X; Trédaniel, J; Le Treut, J; Avrillon, V; Lavolé, A; Westeel, V; Orsini Piocelle, F; Pichon, E; Thiberville, L; et al.